Advance care planning for haemodialysis patients

Background People with chronic kidney disease and end-stage kidney disease (ESKD) have irreversible kidney damage and require renal replacement therapy. In developed countries, haemodialysis has become the most common treatment for people with ESKD. Despite its life-saving potential, haemodialysis